MANAGEMENT

As Senior Vice President of Established Brands at Azurity Pharmaceuticals, Perry leads the commercial strategy and execution for the company’s portfolio of established medicines. Joining Azurity in 2025, Perry focuses on maximizing portfolio performance, defining long-term brand strategy, and strengthening cross-functional collaboration to drive sustained commercial success and increased patient access.

Prior to Azurity, Perry held senior leadership roles spanning corporate strategy, business development, portfolio management, and commercial operations. His track record includes driving transformation, leading high-performing teams, and delivering multimillion-dollar outcomes across both branded and generic product portfolios. His experience includes leading private-label business development and commercial enablement as Vice President at McKesson and serving as Senior Director of Corporate Strategy within McKesson’s CoverMyMeds business, where he shaped long-term growth strategy and product roadmaps. Earlier in his career, he held executive positions at Cosette Pharma, Casper Pharma, and Sun Pharma. Perry holds a Sloan Masters degree from London Business School, a Masters in Engineering from the University of Toledo and a Bachelor of Engineering degree from the Birla Institute of Technology and Science.